Bayforest Capital’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.6K Sell
256
-520
-67% -$127K 0.06% 524
2025
Q4
$197K Sell
776
-2,852
-79% -$716K 0.15% 292
2025
Q3
$898K Buy
3,628
+1,923
+113% +$460K 0.43% 27
2025
Q2
$410K Buy
1,705
+1,140
+202% +$265K 0.18% 230
2025
Q1
$128K Buy
565
+535
+1,783% +$118K 0.06% 455
2024
Q4
$6.17K Buy
+30
New +$6.58K 0.01% 646

Other funds holding STE

Bayforest Capital's STE Position: Q1 2026 in Review

Bayforest Capital reduced its Steris (STE) stake by 67% in Q1 2026, selling an estimated $127K and leaving 256 shares worth $56.6K. The position accounts for 0.06% of the portfolio, ranked #524.

Bayforest Capital first reported a position in STE in Q4 2024 and has held it in 6 quarters since. The position peaked at $898K in Q3 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Bayforest Capital held 256 shares of Steris worth $56.6K as of Q1 2026.
  • Bayforest Capital sold 520 Steris shares in Q1 2026, an estimated $127K.
  • Steris made up 0.06% of Bayforest Capital's portfolio in Q1 2026, its #524 holding.
  • Bayforest Capital first reported a position in Steris in Q4 2024 and has held it in 6 quarters since.
  • Bayforest Capital's Steris position peaked at $898K in Q3 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.